Parameters | Female subjects | Male subjects | p-value |
---|---|---|---|
Low adherence to MD | N = 298 (48.4%) | N = 318 (51.6%) | |
Age (years) | 34.98 ± 12.49 | 33.21 ± 12.69 | 0.082 |
BMI (kg/m2) | 40.04 ± 5.25 | 37.79 ± 8.74 | < 0.001 |
WC (cm) | 112.15 ± 22.02 | 123.19 ± 26.58 | < 0.001 |
hs-CRP (mg/L) | 4.36 ± 3.44 | 3.79 ± 2.91 | 0.026 |
Low CVR (< 1.0 mg/L) (n,%) | 5, 1.7% | 3, 0.9% | χ2 = 0.07, p = 0.792 |
Intermediate CVR (1.0—3.0 mg/L) (n,%) | 119, 39.9% | 149, 46.9% | χ2 = 9.39, p = 0.002 |
High CVR (≥ 3.0 mg/L) (n,%) | 174, 58.4% | 166, 52.2% | χ2 = 0.03, p = 0.868 |
Average adherence to MD | N = 374 (58.6%) | N = 264 (41.4%) | |
Age (years) | 33.58 ± 10.90 | 35.72 ± 10.03 | 0.012 |
BMI (kg/m2) | 35.09 ± 5.47 | 31.77 ± 5.31 | < 0.001 |
WC (cm) | 99.72 ± 17.66 | 104.81 ± 15.89 | < 0.001 |
hs-CRP (mg/L) | 2.31 ± 2.27 | 2.37 ± 1.27 | 0.701 |
Low CVR (< 1.0 mg/L) (n,%) | 89, 23.8% | 4, 1.5% | χ2 = 59.92, p < 0.001 |
Intermediate CVR (1.0—3.0 mg/L) (n,%) | 198, 52.9% | 199, 75.4% | χ2 = 32.20, p < 0.001 |
High CVR (≥ 3.0 mg/L) (n,%) | 87, 23.3% | 61, 23.1% | χ2 = 0.01, p = 0.961 |
High adherence to MD | N = 296 (75.1%) | N = 98 (24.9%) | |
Age (years) | 32.93 ± 9.57 | 37.27 ± 8.93 | < 0.001 |
BMI (kg/m2) | 26.98 ± 5.24 | 26.05 ± 3.57 | 0.103 |
WC (cm) | 80.22 ± 14.79 | 89.04 ± 10.11 | < 0.001 |
hs-CRP (mg/L) | 1.03 ± 1.14 | 1.92 ± 0.60 | < 0.001 |
Low CVR (< 1.0 mg/L) (n,%) | 177, 59.8% | 1, 1.0% | χ2 = 100.33, p < 0.001 |
Intermediate CVR (1.0—3.0 mg/L) (n,%) | 110, 37.2% | 95, 96.9% | χ2 = 103.02, p < 0.001 |
High CVR (≥ 3.0 mg/L) (n,%) | 9, 3.0% | 2, 2.1% | χ2 = 0.03, p = 0.867 |